In the previous papers, we described a method for preparing toxoid from the two major toxic components, HR1 and HR2, isolated from Habu (Trimeresurus lavoviridis) venom. This toxoid, when injected into monkeys, fully protected the animals against the challenge with a certainly lethal dosis of crude venom (Kondo, S. et al., 1971; Kondo, H. et al., 1971b; Kondo, Sadahiro and Murata, 1976) . The toxoid was also immunogenic for man, producing antitoxin titer to such an extent that one can expect significant suppression of envenomation from snake bite (Someya et al., 1972) . However, the immune response of man to HR1-toxoid, a component of the toxoid, was rather poor; besides, the titer produced by HR1-toxoid was not maintained for a long term. The poor response of man to booster injection of HR1-toxoid was also observed (Sadahiro et al., 1978) . Since HR1 is the main toxic component of the venom, improvement of the immunogenicity of HR1-toxoid was required. For this purpose, the effects of various amounts of adjuvants on the immunogenicity of HR1-toxoid were first investigated. The relative immunogenic potency of a toxoid preparation was determined by comparing to that of a reference toxoid and expressed in terms of the immunizing unit (ImU). An ImU was assigned to each of HR1-and HR2-antigens contained in 1 mg protein of the reference toxoid (Sadahiro et al., 1978) . Figure one shows the immunogenicities of HR1-toxoids in guinea pigs as a function of the amount of aluminum added. The toxoid preparations used were HR1-toxoid batches Nos. 2 and 3. The data were taken from our previous paper (Sadahiro et al., 1978) except for 13P4, which was prepared from HR1-toxoid No. 2 and contained 1 mg protein (0.74 mg as HR1-toxoid) and 0.34 mg aluminum per m1, its potency being 39 ImU/ml. It is evident that the amount of aluminum added significantly influences the potency of the toxoid . Addition of aluminum in amounts larger than 2 mg per mg protein was required to attain reasonably high immunogenicity. Incidentally, about 1 mg of aluminum gave the maximum adjuvanticity with HR2-toxoid (data omitted). Monkeys were then immunized with toxoids with various amounts of aluminum added. As shown in Table I , the increase in the amount of aluminum added obviously enhanced the immunogenicity of HR1-toxoid in monkeys , while the effect on HR2-toxoid was negligible. However, it seems impracticable to use aluminum of more than 1 mg/ml because of the unfavorable side reactions .
Levine, Stone and Wyman (1955) and Yamamoto et al. (1978) reported that the adjuvanticity of aluminum compounds to tetanus toxoid differed significantly depending on the kind of aluminum gel used; this was not the case with diphtheria toxoids. Yamamoto et al. (1978) also demonstrated that when used in combination with poly-L-lysine the amount of aluminum necessary to produce the same level of antibody titer as that produced with aluminum alone was significantly reduced. In the light of this information, we tested the effects of other adjuvants on HR1-toxoid. Four kinds of aluminum compounds were prepared according to Yamamoto et al. (1978) with minor modifications. Poly-L-lysine (type V-A) and poly A:U (double strands) were the products of Sigma Chemical Co., St. Louis, MI and P-L Biochemicals, Milwaukee, WI, respectively. Endotoxin of Bordetella pertussis was a gift from Dr. S. Iwasa, Department of General Biologics Control of this institute (refer to Yamamoto et al., 1978) .
Toxoid was prepared from HR1-toxoid separated by gel filtration on Sephadex G-100, followed by chromatography on DEAE-Sephadex A-50, by the method described by Omori-Satoh and Ohsaka (1970) . Two different batches of the toxin (batch Nos. 67A and 70A) were used to prepare the toxoid. Toxoid ing was carried out by the procedure as described (Kondo, S. et al., 1971) . Adjuvants were added by the procedure described by Yamamoto et al. (1978) . Adjuvanticities were compared by the ability to produce anti-HR1 in guinea pigs weighing 350-400 g. The antitoxin titer was estimated by the method described by Kondo, H. et al. (1971a) and expressed in unit (U) per ml. Table II summarizes the effect of various adjuvants. The adjuvanticity of aluminum hydroxide was significantly superior to that of aluminum phosphate and other adjuvants. The difference between the precipitated and adsorbed forms of aluminum compounds was not significant. Addition of poly-L-lysine to aluminum gel was useful reducing the amount of the latter needed. The effect of combined use of aluminum and poly-L-lysine was more evident after the second injection.
The results stated above indicated that aluminum hydroxide may be used to improve the potency of HR1-toxoid. With regard to other adjuvants, combined use of aluminum gel with poly-L-lysine seems promising. Yamamoto Booster injection was given with 0.1 mg in 1 ml of each toxoid without adjuvant. 2) Amounts of aluminum compounds are expressed in those of aluminum.
ppt : precipitated form ad: adsorbed form 3) Groups of 8 guinea pigs each received 1 ml of each preparation, followed by a booster injection with the plain toxoid and bled before and 2 weeks after the 2nd injection.
Figures show the mean anti-HR1 of each group with the fiducial limits (P=0.95) shown in parentheses.
Anti-HR1 titers in Experiment I were determined on the pooled serum of each group and the fiducial limits were estimated by the procedure described by Takahashi et al. (1975). and Murata (1978) stated that the latter compound was not antigenic, even when given in a large amount. However, further experiments will be necessary before deciding the human use of the new adjuvant. 
